bronchial asthma
CONCLUSIONS: The administration of one single weekly dose        of methotrexate 10 mg in adults and 15 in one pediatric patient allowed for a       decrease of approximately 50% in the glucocorticosteroid dosage in this group of        patients with corticosteroid-dependent bronchial asthma with no relevant adverse        reactions during therapy.
CONCLUSIONS: The administration of one single weekly dose        of methotrexate 10 mg in adults and 15 in one pediatric patient allowed for a       decrease of approximately 50% in the glucocorticosteroid dosage in this group of         @OBJECT$   @PREDICAT$  corticosteroid-dependent  @SUBJECT$  with no relevant adverse        reactions during therapy.